bladder cancer
Conditions
Interventions
control group:Conventional bladder infusion method
Intervention group:Improve bladder perfusion environment
Optimize bladder perfusion measures
Training and supervision of operators
Strengthen patient health education
Sponsors
Shanxi Bethune Hospital
Eligibility
Sex/Gender
All
Age
1 Years to 80 Years
Inclusion criteria
Inclusion criteria: ? Adopting transurethral bladder tumor resection surgery for treatment, and the intraoperative pathological diagnosis is non muscular infiltrating epithelial carcinoma; ? Age range: < 80 years old; ? Bladder infusion chemotherapy drugs have been evaluated by doctors as suitable for the use of pirarubicin; ? Those who have reading comprehension and can communicate normally; ? Sign the informed consent form.
Exclusion criteria
Exclusion criteria: ? Urethral stenosis; ? Participate in other clinical trials; ? Individuals with language communication disorders, mental disorders, or cognitive impairments; ? Severe complications of the urinary system or other systems (such as severe infection, malignant hypertension, severe cerebrovascular accident, myocardial infarction, heart failure, etc.) that prevent normal chemotherapy; ? Patients with a history of malignancies other than bladder cancer; ? During the research period, I was unable to continue participating in the research due to relocation or other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life;Implementation rate of standard bladder infusion measures; | — |
Secondary
| Measure | Time frame |
|---|---|
| Anxiety;Ddepressed;Drug overflow rate;The incidence of chemical cystitis;Bladder perfusion knowledge score; | — |
Countries
China
Contacts
Public ContactZhang Wenjin
Shanxi Bethune Hospital
Outcome results
None listed